Lupin's Famotidine ANDA217432 Receives Abbreviated Approval from FDA
Lupin has received an Abbreviated Approval (AP) for its ANDA217432 application for Famotidine.
Therapeutic Area
Therapeutic area intelligence for H2 Antagonist with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.